Author/Authors :
Rahnama’i, Mohammad Sajjad Urology Department - Uniklinik RWTH Aachen - Germany - Society of Urological Research and Education (SURE) - Heerlen - The Netherlands , Javan, Aida Society of Urological Research and Education (SURE) - Heerlen - The Netherlands - Urology Department - Radboud University Nijmegen - Nijmegen - The Netherlands , Vyas, Navita Pain and Rehab Medicine - Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute - Mumbai, India , Lovasz, Sandor Rózsakert Medical Center - Budapest - Hungary , Singh, Neelanjana PSRI Hospital - Sheikh Sarai - New Delhi, India , Cervigni, Mauro Rome - Italy , Pandey, Sanjay Kokilaben Dhirubhai Ambani Hospital and Research institute - Mumbai, India , Wyndaele, Jean Jacques University of Antwerp - Antwerp - Belgium , Taneja, Rajesh Indraprastha Apollo Hospitals - New Delhi - India
Abstract :
Purposeof the Meeting: Bladder pain syndrome/interstitial cystitis is a prevalent but underserved disease. At the Global Interstitial
Cystitis/Bladder Pain Syndrome Society (GIBS) meeting, the organization and participants were committed to delivering word-class
expertise and collaboration in research and patient care. Under the umbrella of GIBS, leading research scholars from different backgrounds
and specialties, as well as clinicians, from across the globe interested in the science and art of practice of Bladder Pain
Syndrome (BPS)/Interstitial Cystitis (IC) were invited to deliberate on various dimensions of this disease. The meeting aimed to have
global guidelines to establish firm directions to practicing clinicians and patients alike on the diagnosis and treatment of this disease
entity. Chronic Pelvic Pain Syndrome (CPPS) is defined by pain in the pelvic area that can have different etiologies. This can
be due to urologic, gynecologic, musculoskeletal, gastrointestinal, neurologic, and autoimmune or rheumatologic diseases. At the
GIBS meeting held in Mumbai, India, in August 2019, a multidisciplinary expert panel of international urologists, gynecologists,
pain specialists, and dietitians took part in a think tank to discuss the development of evidence-based diagnostic and treatment
algorithms for BPS/IC.
Summary of Presented Findings: The diagnosis of BPS/IC is difficult in daily clinical practice. Patients with BPS/IC present with a
variety of signs and symptoms and clinical test results. Hence, they might be misdiagnosed or underdiagnosed, and the correct diagnosis
might take a long time. Agood history and physical examination, along with cystoscopy, is a must for the diagnosis of IC/BPS.
For the treatment, besides lifestyle management and dietary advice, oral medication and bladder instillation therapy, botulinum
toxin, and sacral neuromodulation were discussed. The innovation in bladder instillation applicators, as well as battery-free neuromodulation
through the tibial nerve, was discussed, as well.
Recommendation for Future Research: As BPS/IC is complex, for many patients, several treatments are necessary at the same
time. This was presented at GIBS 2019 as the piano model. In this way, a combination of treatments is tailored to an individual
patient depending on the symptoms, age, and patients’ characteristics. In the art of medicine, especially when dealing with BPS/IC
patients, pressing the right key at the right time makes the difference.
Keywords :
Bladder Pain Syndrome , Interstitial Cystitis Beyond Horizon , Global Interstitial Cystitis , Bladder Pain Society